Light transmission. II. Instruments for making in-vivo light transmission measurements

1979 ◽  
Vol 35 (9) ◽  
pp. 1266-1268
Author(s):  
E. Viggiani
Keyword(s):  
Light Transmission ◽  
Transmission Measurements

Adenosine Diphosphate (ADP)-Induced ⍺-Granules Release from Platelets of Native Whole Blood Is Reduced by Ticlopidine but Not by Aspirin or Dipyridamole

1986 ◽  
Vol 56 (02) ◽  
pp. 147-150 ◽  
Author(s):  
V Pengo ◽  
M Boschello ◽  
A Marzari ◽  
M Baca ◽  
L Schivazappa ◽  
...  
Keyword(s):  
Whole Blood ◽  
Light Transmission ◽  
Ex Vivo ◽  
Early Stage ◽  
Shape Change ◽  
Adenosine Diphosphate ◽  
Dose Dependent ◽  
Plateletderived Growth Factor ◽  
Platelet Shape

SummaryA brief contact between native whole blood and ADP promotes a dose-dependent release of platelet a-granules without a fall in the platelet number. We assessed the “ex vivo” effect of three widely used antiplatelet drugs, aspirin dipyridamole and ticlopidine, on this system. Aspirin (a single 800 mg dose) and dipyridamole (300 mg/die for four days) had no effect, while ticlopidine (500 mg/die for four days) significantly reduced the a-granules release for an ADP stimulation of 0.4 (p <0.02), 1.2 (p <0.01) and 2 pM (p <0.01). No drug, however, completeley inhibits this early stage of platelet activation. The platelet release of α-granules may be related to platelet shape change of the light transmission aggregometer and may be important “in vivo” by enhancing platelet adhesiveness and by liberating the plateletderived growth factor.

scholarly journals Development of a potent embryonic chick lens model for studying congenital cataracts in vivo

2021 ◽  
Vol 4 (1) ◽  
Author(s):  
Zhen Li ◽  
Sumin Gu ◽  
Yumeng Quan ◽  
Kulandaiappan Varadaraj ◽  
Jean X. Jiang
Keyword(s):  
Light Transmission ◽  
Genetic Diseases ◽  
Gene Mutations ◽  
Underlying Mechanism ◽  
Dominant Negative ◽  
Lens Model ◽  
Embryonic Chick ◽  
Congenital Cataracts ◽  
Chick Lens

AbstractCongenital cataracts are associated with gene mutations, yet the underlying mechanism remains largely unknown. Here we reported an embryonic chick lens model that closely recapitulates the process of cataract formation. We adopted dominant-negative site mutations that cause congenital cataracts, connexin, Cx50E48K, aquaporin 0, AQP0R33C, αA-crystallin, CRYAA R12C and R54C. The recombinant retroviruses containing these mutants were microinjected into the occlusive lumen of chick lenses at early embryonic development. Cx50E48K expression developed cataracts associated with disorganized nuclei and enlarged extracellular spaces. Expression of AQP0R33C resulted in cortical cataracts, enlarged extracellular spaces and distorted fiber cell organization. αA crystallin mutations distorted lens light transmission and increased crystalline protein aggregation. Together, retroviral expression of congenital mutant genes in embryonic chick lenses closely mimics characteristics of human congenital cataracts. This model will provide an effective, reliable in vivo system to investigate the development and underlying mechanism of cataracts and other genetic diseases.

scholarly journals Light transmission measurements and phototherapy eyepatches.

1991 ◽  
Vol 66 (1 Spec No) ◽  
pp. 59-61 ◽  
Author(s):  
J Robinson ◽  
M J Moseley ◽  
A R Fielder ◽  
S C Bayliss
Keyword(s):  
Light Transmission ◽  
Transmission Measurements

scholarly journals The Induction of Platelet Aggregates in Healthy Subjects by Venousocclusion

1977 ◽  
Author(s):  
D.A. F. Chamone ◽  
J. Vermylen
Keyword(s):  
Healthy Subjects ◽  
Light Transmission ◽  
Diastolic Pressure ◽  
Platelet Rich Plasma ◽  
In Vivo Evaluation ◽  
Modified Method ◽  
Circulating Platelet Aggregates ◽  
Platelet Aggregates ◽  
Set Up

Circulating platelet aggregates have been observed in various clinical conditions (Wu and Hoak, Lancet, 1974, ii, 924). Using a slightly modified method, we have found that platelet aggregates can be induced in vivo in healthy subjects.Nine volunteers (7 males, 2 females, age 23-38 years) were studied. Blood was drawn from an antecubital vein of one arm immediately before and of the other arm after twenty minutes of occlusion midway between systolic and diastolic pressure. The ratio of the platelet count in platelet-rich plasma (PRP) obtained from blood collected on forma lin-EDTA to that from blood collected on EDTA only was 0.934 + 0.028 (mean ± S.E .) before and 0.768 ± 0.033 after occlusion (p < 0.001 ). Spontaneous aggregation in PRP, measured as percent increase in light transmission during 10 minutes of stirring in the a gg re gome ter, was 4 .20 ± 1.17 before and 3 .80 + I .69 after occlusion (p > 0 .1).This system may help elucidate some of the mechanisms involved in the generation of circulating platelet aggregates. It may also constitute a simple set-up for the in vivo evaluation of drugs affecting platelet function.

scholarly journals 3D Reconstruction of HvRNASET2 Molecule to Understand Its Antibacterial Role

2020 ◽  
Vol 21 (24) ◽  
pp. 9722
Author(s):  
Nicolò Baranzini ◽  
Laura Pulze ◽  
Marcella Reguzzoni ◽  
Rossella Roncoroni ◽  
Viviana Teresa Orlandi ◽  
...  
Keyword(s):  
Light Transmission ◽  
Three Dimensional ◽  
Lipoteichoic Acid ◽  
Type I ◽  
Phagocytic Cells ◽  
In Vivo Experiments ◽  
Macrophage Phagocytosis ◽  
Bacterial Aggregates

Recent studies performed on the invertebrate model Hirudo verbana (medicinal leech) suggest that the T2 ribonucleic enzyme HvRNASET2 modulates the leech’s innate immune response, promoting microbial agglutination and supporting phagocytic cells recruitment in challenged tissues. Indeed, following injection of both lipoteichoic acid (LTA) and Staphylococcus aureus in the leech body wall, HvRNASET2 is expressed by leech type I granulocytes and induces bacterial aggregation to aid macrophage phagocytosis. Here, we investigate the HvRNASET2 antimicrobial role, in particular assessing the effects on the Gram-negative bacteria Escherichia coli. For this purpose, starting from the three-dimensional molecule reconstruction and in silico analyses, the antibacterial activity was evaluated both in vitro and in vivo. The changes induced in treated bacteria, such as agglutination and alteration in wall integrity, were observed by means of light, transmission and scanning electron microscopy. Moreover, immunogold, AMPs (antimicrobial peptides) and lipopolysaccharide (LPS) binding assays were carried out to evaluate HvRNASET2 interaction with the microbial envelopes and the ensuing ability to affect microbial viability. Finally, in vivo experiments confirmed that HvRNASET2 promotes a more rapid phagocytosis of bacterial aggregates by macrophages, representing a novel molecule for counteracting pathogen infections and developing alternative solutions to improve human health.

Platelet Shape Change Evoked by Selective Activation of P2X1 Purinoceptors with α,β-Methylene ATP

2001 ◽  
Vol 85 (02) ◽  
pp. 303-308 ◽  
Author(s):  
Michael Rolf ◽  
Charles Brearley ◽  
Martyn Mahaut-Smith
Keyword(s):  
Inhibitory Action ◽  
Light Transmission ◽  
Shape Change ◽  
Second Messengers ◽  
Receptor Activation ◽  
Selective Activation ◽  
The Relationship ◽  
Shape Changes ◽  
Platelet Shape

SummarySimultaneous measurements of [Ca2+]i and light transmission were used to examine the relationship between P2X1 receptor activation and functional platelet responses. The P2X1 agonist α,β-MeATP evoked a transient [Ca2+]i increase and a reversible decrease in light transmission; both responses required external Ca2+ and the nucleotidase apyrase. The transmission response was due to shape change only, verified by scanning electron microscopy and insensitivity to Reopro, a GPIIbIIIa antagonist. α,β-MeATP stimulated smaller shape changes than ADP, however P2X1 responses had a lifespan of <2 h following resuspension in saline and may be considerably larger in vivo. A peak [Ca2+]i increase of >50 nM was required for detectable shape change. Overlap of concentration-response relationships for α,β-MeATP-evoked [Ca2+]i and shape change suggests that other second messengers are not involved. Therefore, the physiological P2X1 agonist ATP can contribute to platelet activation, in contrast to its previously described inhibitory action at metabotropic platelet purinoceptors.

Comparison of Two Coating Material Reflections of Hollow Light Guide Tube

2014 ◽  
Vol 1041 ◽  
pp. 412-415
Author(s):  
Lenka Janečková ◽  
Stanislav Darula ◽  
Daniela Bošová
Keyword(s):  
Light Guide ◽  
Light Transmission ◽  
Transmission Efficiency ◽  
Luminous Flux ◽  
Coating Material ◽  
Guide Tube ◽  
Coating Materials ◽  
Two Samples ◽  
Transmission Measurements ◽  
Light Guides

This paper discusses tube transmission efficiency of two straight hollow light guides. Two samples with diameter of 530 mm and length 1170 mm were investigated under the artificial sky in the laboratory at ICA SAS in Bratislava. The entering luminous flux was calculated from measured illuminance in the point located on the top of light guide. Below the bottom of the light guide was located a set of measuring points on the special construction in the shape of a cross. In these points, one by one, the elementary illuminances were measured and the luminous fluxes leaving the light guide were calculated. Paper presents methodology for laboratory light transmission measurements and discusses effects of two various coating materials on light transmission efficiency of hollow light guides.

Ticagrelor reversal:in vitroassessment of four haemostatic agents

2017 ◽  
Vol 70 (9) ◽  
pp. 733-739 ◽  
Author(s):  
Leyla Calmette ◽  
Anne-Céline Martin ◽  
Bernard Le Bonniec ◽  
Diane Zlotnik ◽  
Isabelle Gouin-Thibault ◽  
...  
Keyword(s):  
Platelet Aggregation ◽  
Light Transmission ◽  
Maximum Amplitude ◽  
Platelet Inhibition ◽  
Factor Vii ◽  
Recombinant Activated Factor Vii ◽  
Impedance Aggregometry ◽  
Haemostatic Agents

AimManagement of ticagrelor-induced bleeding is challenging as platelet transfusion is ineffective. An effective strategy is needed. This study aimed to investigatein vitrothe efficacy of four haemostatic drugs (HDs), namely recombinant activated factor VII (rFVIIa), fibrinogen concentrate (Fib), tranexamic acid (TXA) and factor XIII concentrate (FXIII) to improve the haemostatic capacity in the presence of ticagrelor.MethodsBlood was spiked with ticagrelor then supplemented by either HD or control. Several assays were performed: ADP-induced platelet aggregation measured by impedance aggregometry, light transmission and two global assays, thrombolastography with the platelet mapping device (TEG-PM) and a platelet-dependent thrombin generation assay (TGA).ResultsTicagrelor inhibited ADP-induced platelet aggregation and decreased the clot strength maximum amplitude (MA) in TEG-PMADP. None of the HDs corrected these parameters. However, rFVIIa shortened the coagulation time R using TEG-PMthrombinand the time to peak prolonged by ticagrelor in TGA. Fib increased MAthrombinand FXIII decreased LY30. TXA had no effects.ConclusionsWhereas none of the HDs corrected ticagrelor-induced platelet inhibition, rFVIIa shortened coagulation times, Fib increased clot firmness and FXIII decreased fibrinolysis. Consequently, they may bypass ticagrelor effects by acting on fibrin formation or fibrinolysis. Further studies are needed to confirm these datain vivo.

Sign in / Sign up

Export Citation Format

Share Document